
Christopher C. Caillouet
Examiner (ID: 8951, Phone: (571)270-3968 , Office: P/1745 )
| Most Active Art Unit | 1745 |
| Art Unit(s) | 1791, 1745 |
| Total Applications | 862 |
| Issued Applications | 546 |
| Pending Applications | 67 |
| Abandoned Applications | 259 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4977998
[patent_doc_number] => 20070219231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/578828
[patent_app_country] => US
[patent_app_date] => 2005-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7882
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219231.pdf
[firstpage_image] =>[orig_patent_app_number] => 11578828
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/578828 | Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof | Apr 12, 2005 | Issued |
Array
(
[id] => 5649924
[patent_doc_number] => 20060135659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Novel flame retarding compounds'
[patent_app_type] => utility
[patent_app_number] => 11/104057
[patent_app_country] => US
[patent_app_date] => 2005-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15226
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135659.pdf
[firstpage_image] =>[orig_patent_app_number] => 11104057
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/104057 | Flame retarding compounds | Apr 11, 2005 | Issued |
Array
(
[id] => 7978059
[patent_doc_number] => 08071777
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine'
[patent_app_type] => utility
[patent_app_number] => 11/578530
[patent_app_country] => US
[patent_app_date] => 2005-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4750
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071777.pdf
[firstpage_image] =>[orig_patent_app_number] => 11578530
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/578530 | Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine | Apr 11, 2005 | Issued |
Array
(
[id] => 7234094
[patent_doc_number] => 20050256158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'PGD2 receptor antagonists for the treatment of inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 11/101208
[patent_app_country] => US
[patent_app_date] => 2005-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 149205
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256158.pdf
[firstpage_image] =>[orig_patent_app_number] => 11101208
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/101208 | PGD2 receptor antagonists for the treatment of inflammatory diseases | Apr 6, 2005 | Issued |
Array
(
[id] => 582076
[patent_doc_number] => 07452995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-18
[patent_title] => 'Aryl aniline β2 adrenergic receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 11/102197
[patent_app_country] => US
[patent_app_date] => 2005-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20333
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/452/07452995.pdf
[firstpage_image] =>[orig_patent_app_number] => 11102197
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/102197 | Aryl aniline β2 adrenergic receptor agonists | Apr 6, 2005 | Issued |
Array
(
[id] => 6913004
[patent_doc_number] => 20050176762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/100256
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17312
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176762.pdf
[firstpage_image] =>[orig_patent_app_number] => 11100256
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/100256 | Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists | Apr 5, 2005 | Abandoned |
Array
(
[id] => 471058
[patent_doc_number] => RE039682
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2007-06-05
[patent_title] => 'Farnesyl derivatives and pharmaceutical compositions containing them'
[patent_app_type] => reissue
[patent_app_number] => 11/093255
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 22
[patent_no_of_words] => 6828
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039682.pdf
[firstpage_image] =>[orig_patent_app_number] => 11093255
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/093255 | Farnesyl derivatives and pharmaceutical compositions containing them | Mar 29, 2005 | Issued |
Array
(
[id] => 7005839
[patent_doc_number] => 20050171152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Method for the synthesis of quinoline derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/093701
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9392
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171152.pdf
[firstpage_image] =>[orig_patent_app_number] => 11093701
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/093701 | Method for the synthesis of quinoline derivatives | Mar 29, 2005 | Abandoned |
Array
(
[id] => 7112000
[patent_doc_number] => 20050209456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Quinolinone derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/092137
[patent_app_country] => US
[patent_app_date] => 2005-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50377
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209456.pdf
[firstpage_image] =>[orig_patent_app_number] => 11092137
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/092137 | Quinolinone derivatives | Mar 28, 2005 | Issued |
Array
(
[id] => 7005825
[patent_doc_number] => 20050171138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Flavone acetic acid analogs and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/091054
[patent_app_country] => US
[patent_app_date] => 2005-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4377
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171138.pdf
[firstpage_image] =>[orig_patent_app_number] => 11091054
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/091054 | Flavone acetic acid analogs and methods of use thereof | Mar 27, 2005 | Abandoned |
Array
(
[id] => 5070243
[patent_doc_number] => 20070191345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => '3-((Hetero)arylsulfonyl)-8-\'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disorders'
[patent_app_type] => utility
[patent_app_number] => 10/599002
[patent_app_country] => US
[patent_app_date] => 2005-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6998
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191345.pdf
[firstpage_image] =>[orig_patent_app_number] => 10599002
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599002 | 3-((Hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disorders | Mar 23, 2005 | Abandoned |
Array
(
[id] => 5113670
[patent_doc_number] => 20070197586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => '8-Hydroxy-5-[(-Hydroxy-2-[[ (1R)-2-(4-Methoxyphenyl)-1-Methylethyl] Amino][Ethyl]-2(1H)-Quinolinone Monohydrochloride In Crystalline Form And The Process For Its Preparation'
[patent_app_type] => utility
[patent_app_number] => 10/593571
[patent_app_country] => US
[patent_app_date] => 2005-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2821
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197586.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593571
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593571 | 8-Hydroxy-5-[(-Hydroxy-2-[[ (1R)-2-(4-Methoxyphenyl)-1-Methylethyl] Amino][Ethyl]-2(1H)-Quinolinone Monohydrochloride In Crystalline Form And The Process For Its Preparation | Mar 23, 2005 | Abandoned |
Array
(
[id] => 6952271
[patent_doc_number] => 20050227365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => '8-Hydroxyquinoline tripodal metal ion probes'
[patent_app_type] => utility
[patent_app_number] => 11/086987
[patent_app_country] => US
[patent_app_date] => 2005-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 4537
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227365.pdf
[firstpage_image] =>[orig_patent_app_number] => 11086987
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/086987 | 8-hydroxyquinoline tripodal metal ion probes | Mar 22, 2005 | Issued |
Array
(
[id] => 92611
[patent_doc_number] => 07732612
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => '7-amino alkylidenyl-heterocyclic quinolones and naphthyridones'
[patent_app_type] => utility
[patent_app_number] => 11/084987
[patent_app_country] => US
[patent_app_date] => 2005-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25756
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732612.pdf
[firstpage_image] =>[orig_patent_app_number] => 11084987
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/084987 | 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones | Mar 20, 2005 | Issued |
Array
(
[id] => 7070183
[patent_doc_number] => 20050245568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Process for making montelukast and intermediates therefor'
[patent_app_type] => utility
[patent_app_number] => 11/081689
[patent_app_country] => US
[patent_app_date] => 2005-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6602
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245568.pdf
[firstpage_image] =>[orig_patent_app_number] => 11081689
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/081689 | Process for making montelukast and intermediates therefor | Mar 16, 2005 | Issued |
Array
(
[id] => 341759
[patent_doc_number] => 07501517
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-10
[patent_title] => 'Process for making montelukast and intermediates therefor'
[patent_app_type] => utility
[patent_app_number] => 11/081695
[patent_app_country] => US
[patent_app_date] => 2005-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6718
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/501/07501517.pdf
[firstpage_image] =>[orig_patent_app_number] => 11081695
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/081695 | Process for making montelukast and intermediates therefor | Mar 16, 2005 | Issued |
Array
(
[id] => 7020183
[patent_doc_number] => 20050222202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Highly pure cilostazol and an improved process for obtaining same'
[patent_app_type] => utility
[patent_app_number] => 11/080460
[patent_app_country] => US
[patent_app_date] => 2005-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10983
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222202.pdf
[firstpage_image] =>[orig_patent_app_number] => 11080460
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/080460 | Highly pure cilostazol and an improved process for obtaining same | Mar 15, 2005 | Issued |
Array
(
[id] => 7111821
[patent_doc_number] => 20050209277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Process for the synthesis of CXCR4 antagonist'
[patent_app_type] => utility
[patent_app_number] => 11/077896
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12401
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209277.pdf
[firstpage_image] =>[orig_patent_app_number] => 11077896
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/077896 | Process for the synthesis of CXCR4 antagonist | Mar 10, 2005 | Issued |
Array
(
[id] => 281967
[patent_doc_number] => 07553967
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-30
[patent_title] => '1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections'
[patent_app_type] => utility
[patent_app_number] => 11/076936
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10418
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/553/07553967.pdf
[firstpage_image] =>[orig_patent_app_number] => 11076936
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/076936 | 1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections | Mar 10, 2005 | Issued |
Array
(
[id] => 4978009
[patent_doc_number] => 20070219242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Quinolin-4-Ones as Inhibitors of Retroviral Integrase for the Treatment of Hiv, Aids and Aids Related Complex (Arc)'
[patent_app_type] => utility
[patent_app_number] => 10/591679
[patent_app_country] => US
[patent_app_date] => 2005-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17401
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20070219242.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591679
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591679 | Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC) | Mar 8, 2005 | Issued |